Check the

DYSART PRESS LIMITED

Company
DYSART PRESS LIMITED (05813566)

DYSART PRESS

Phone: 08008 008 000
B⁺ rating

ABOUT DYSART PRESS LIMITED

So read exclusive health stories, hear about the latest products, join in debate and browse the archives. Explore, discuss, enjoy – but first…

A well-respected moderator, both at public events and for private meetings, Victoria helps companies to define both identity and message. She produces blue-chip copy for corporate clients such as the Thrombosis Research Institute, and consults and advises for PR and communications companies including Euro RSCG, Red Door Communications, the Racepoint Group, Ruder Finn Clark, HCA, Just Health and Sweet PR.

Dysart Press

Dysart Press Ltd is a British media company, set up by award-winning journalist Victoria Lambert, specialising in journalism, publishing, corporate work (copy writing, consulting and conference coverage/reports), moderating, talks (including speeches and chairing forums) and training. It is the publisher of underthescope.co.uk

Calling on a team of proven and experienced journalists and PR professionals, Dysart Press can provide solutions to tackle any scale of communications project.

Please contact Dysart Press about how we can help your organisation:

For five years, Johnny found himself going to the doctor, complaining of aches and pains, and feeling unable to do something as simple as run upstairs. There is no one simple test for MS; doctors typically diagnose it through an accumulation of symptoms, although it can be confirmed in more than 90 per cent of cases by an MRI scan, which will reveal areas of damage, called lesions, on the spinal cord. On doctors’ advice, Johnny would embark on a health kick: get more sleep, stop drinking. But when the day came that his whole body felt numb, enough was enough. Johnny visited a doctor and this time refused to leave – “Well, I couldn’t walk” – until something was done and he was examined properly.

Johnny has tried several other treatments, including an anti-spastic agent, Baclofen, and Aimspro, a controversial drug derived from a serum made of goats’ blood, which has never been formally trialled. It is only available privately and Johnny found it too expensive. Now he relies on a combination of the sedative diazepam and anti-depressant amitriptyline, plus he is trying an experimental treatment, LDN, or low-dose naltrexone, which is believed to boost the immune system by increasing production of the body’s “natural” painkillers, endorphins. Again, it has to be paid for as it is not available on the NHS. “This is a most effective drug for me – the other day my legs felt really strong. “More importantly, it is giving me my personality back.”

The weakness in his legs has been one of his greatest frustrations. “At first I only needed one stick, then I needed crutches, but I got fed up with being barred from pubs and clubs because the bouncers thought I was drunk. Walking was painful and unsteady so I had to accept that I needed a wheelchair. At first it was awful, but now I have a groovy new French chair, which helps.”

Sadly, in the past month, the spasms have begun to affect his arms and Johnny has found himself making excuses not to get the drawing board out. So this talented artist, who discovered his passion at 10 when he saw a comic book, immediately surrendered his football to a friend and began to draw and draw for days on end, has found himself almost frightened to begin work for fear of what he might no longer be able to do. ”I am grateful for the amount of drawing I have done so far, but I’m scared to put pen to paper now. The last time I drew anything was last year.” However, he remains remarkably upbeat. He has the strong support of friends and family – sisters Jane and Sarah, plus that niece who is now at medical school. “The more intense the disease gets, the more intense my relationships become. I never feel excluded because people are really sweet and they forget I am ill. My mum has been particularly helpful.”

Johnny accepts his fate with remarkable ease. “I am staring death in the face and I want to move on. I believe in euthanasia. I want to go my way when the time comes. And I am not demoralised, but I am very angry – this disease makes me angry. ”But I’m not bitter – when I see kids running up the street, having fun, skateboarding, doing what they do, I say thank God for your myelin sheath and may you always be happy and healthy.”

was made by Animal Monday Production and funded by the Channel 4 British Documentary Foundation and the Wellcome Trust. MS Society Helpline: 0800 800 8000

KEY FINANCES

Year
2017
Assets
£25.51k ▲ £6.61k (34.99 %)
Cash
£0k ▼ £-11.42k (-100.00 %)
Liabilities
£26.07k ▲ £7.63k (41.38 %)
Net Worth
£-0.56k ▼ £-1.02k (-224.23 %)

REGISTRATION INFO

Company name
DYSART PRESS LIMITED
Company number
05813566
Status
Active
Categroy
Private Limited Company
Date of Incorporation
11 May 2006
Age - 18 years
Home Country
United Kingdom

CONTACTS

Website
www.underthescope.co.uk
Phones
08008 008 000
Registered Address
C/O APPROVED ACCOUNTING LTD,
36 FIFTH AVENUE,
HAVANT,
HAMPSHIRE,
ENGLAND,
PO9 2PL

ECONOMIC ACTIVITIES

90030
Artistic creation

THIS BUSINESS IN SOCIAL MEDIA

Facebook
View
Twitter
Follow

LAST EVENTS

29 Jul 2016
Total exemption small company accounts made up to 31 March 2016
11 May 2016
Annual return made up to 11 May 2016 with full list of shareholders Statement of capital on 2016-05-11 GBP 1,000
05 Jan 2016
Total exemption small company accounts made up to 31 March 2015

See Also


Last update 2018

DYSART PRESS LIMITED DIRECTORS

Nicholas Power Richard Le Poer Trench

  Acting
Appointed
11 May 2006
Role
Secretary
Address
19 Woodbury Avenue, Petersfield, Hampshire, United Kingdom, GU32 2ED
Name
LE POER TRENCH, Nicholas Power Richard

Victoria Frances Le Poer Trench

  Acting
Appointed
11 May 2006
Occupation
Journalist
Role
Director
Age
60
Nationality
British
Address
19 Woodbury Avenue, Petersfield, Hampshire, United Kingdom, GU32 2ED
Country Of Residence
England
Name
LE POER TRENCH, Victoria Frances

REVIEWS


Check The Company
Very good according to the company’s financial health.